Product Description
Radiation for Locally Advanced HPV Positive Oropharynx Cancer (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02945631)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Icahn School of Medicine at Mount Sinai
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| Quarterback 22 | N/A |
Active, not recruiting |
Oropharyngeal Cancer |
2027-12-01 |